VC
Value Add VC
โšกHomePulseโšกHelpful Apps๐Ÿ“Blog
โ† Value Add PulseIPO~$1B valuation

SeeQC Files S-1 for Nasdaq IPO to Fund Digital Quantum Computing Chips

SeeQC, which builds digital quantum-computing infrastructure, filed a Form S-1 to list on the Nasdaq Global Market under ticker 'SEQC,' paired with a $65 million PIPE financing that values the combined entity at roughly $1 billion. The company integrates superconducting single-flux-quantum logic with cryogenic CMOS to shrink the wiring and heat load of quantum systems -- reporting $4.2 million in 2025 revenue against a $12.2 million net loss.

SEQC (Nasdaq)
Ticker
~$1B
Valuation
$65M
PIPE
$4.2M (up from $0.8M)
2025 Revenue
$12.2M
2025 Net Loss
TC
Trace Cohen
Early-stage VC & angel ยท Founder, New York Venture Partners
June 29, 2026
2 min read
KEY TAKEAWAYS FOR VCs & FOUNDERS
1

Quantum computing is becoming an IPO category, not just a research program

2

SeeQC's chip-level integration attacks one of quantum's hardest scaling bottlenecks

3

A ~$1B valuation tests public appetite for pre-profit deep-tech outside the AI trade

4

It widens a 2026 IPO pipeline stretching well beyond marquee AI labs

TC
The VC Read ยท Trace's TakeTrace Cohen

Quantum is quietly becoming an IPO category, and SeeQC's angle is the smart one: don't try to build the whole quantum computer, build the control-and-readout chips every quantum computer will need. That's the picks-and-shovels play, modality-agnostic, and it sidesteps the qubit arms race. The valuation is the hard part to swallow -- a billion dollars on $4.2M of revenue is buying a decade-out future. For public investors this is venture risk in a ticker, and the SPAC structure adds its own dilution. Worth watching as a read on whether the open IPO window extends to genuinely speculative deep-tech, not just AI.

๐Ÿ“ˆ 2026 IPO Tracker โ†’๐Ÿ“Š IPO Pipeline โ†’

SeeQC, a developer of digital quantum-computing infrastructure, filed a Form S-1 with the SEC on June 29, 2026 to list on the Nasdaq Global Market under the ticker 'SEQC,' according to SEC EDGAR and TradingView. The listing comes via a combination with Allegro Merger Corp. that includes a $65 million PIPE financing and values the combined entity at roughly $1 billion.

SeeQC's technical pitch targets one of quantum computing's least-discussed but most punishing bottlenecks: the control and readout layer. Rather than chase qubit counts alone, the company builds superconducting digital control, readout and quantum-classical integration, operating its own in-house superconducting foundry. Its platform fuses single-flux-quantum (SFQ) logic with cryogenic CMOS to deliver ultra-low-power control, high-throughput readout and on-chip multiplexing -- reducing the dense wiring, thermal load and system complexity that make large quantum machines so hard to scale.

โ€œSeeQC reported $4.2 million in revenue for 2025, up sharply from $800,000 in 2024, against a net loss of $12.2 million (versus $10.1 million the prior year).โ€

The financials underscore that this is a frontier-tech bet, not a profitable business. SeeQC reported $4.2 million in revenue for 2025, up sharply from $800,000 in 2024, against a net loss of $12.2 million (versus $10.1 million the prior year). Those are research-stage numbers; the public listing is fundamentally a capital raise to fund years of expensive development, much like other quantum names that have tapped public markets.

The competitive landscape is crowded with better-known names. SeeQC competes -- and in some cases partners -- with full-stack quantum players like IBM, Google, IonQ, Rigetti and Quantinuum, the last of which went public earlier in 2026 raising $1.7 billion at a $15.6 billion valuation. SeeQC's differentiation is its focus on the digital infrastructure layer rather than building an entire quantum computer, a picks-and-shovels position betting that every quantum system will need better control electronics regardless of qubit modality.

The bear case is stark: quantum computing remains years from broad commercial utility, SeeQC is deeply unprofitable, and a ~$1 billion valuation on $4.2 million of revenue prices in a future that may take a decade to arrive -- if it does. SPAC-style combinations also carry their own dilution and execution risks. What to watch: the final terms and trading debut, milestones for SeeQC's chip integration, and whether public investors keep an appetite for speculative deep-tech as the broader IPO window stays open.

ShareXLinkedInEmail

Originally reported by SEC EDGAR (Form S-1). Analysis and editorial commentary by Value Add Pulse.

โ† Back to Pulse

Markets Now

live
S&P 500โ–ฒ+1.13%
7,440.43
NASDAQโ–ฒ+1.82%
25,820.15
NVDAโ–ผ-0.39%
$194.97
MSFTโ–ฒ+4.46%
$368.57
AAPLโ–ฒ+2.40%
$281.74
GOOGLโ–ฒ+2.89%
$353.65
METAโ–ฒ+3.63%
$562.60
AMZNโ–ฒ+5.78%
$240.14

Read Next

IPOMost $1B+ exits since 2021

Q2 2026 Delivers the Most Billion-Dollar Startup Exits Since the 2021 Peak

Startup exits worth $1 billion or more were more numerous in Q2 2026 than at any point since the 2021 market peak, according to Crunchbase data -- powered by SpaceX's record IPO (a $2.1 trillion first-day market cap on $75 billion raised), Cerebras's and Quantinuum's debuts, and SpaceX's $60 billion acquisition of Cursor. The quarter signals the long-frozen exit window has decisively reopened for late-stage tech.

IPOS-1 filed

SunPower Files S-1 as Reborn Residential Solar Company Eyes Public Markets

SunPower filed a Form S-1 with the SEC on June 29, registering shares for resale as the rebuilt residential and small-business solar company steps toward the public markets. Trading under ticker SPWR, the company is pitching an end-to-end offering -- technology platform, financing and high-performance equipment -- in a U.S. solar market reshaped by shifting incentives and consolidation.

IPOS-1MEF filed

Spine-Surgery Device Maker Tenon Medical Files to Raise Fresh Capital

Tenon Medical filed an S-1MEF with the SEC on June 29, registering additional shares to support a public offering as the small-cap medical-device company funds the commercialization of its sacroiliac (SI) joint fusion system. The filing is a window into the steady, less-glamorous flow of medtech issuers tapping public markets even as AI and mega-IPOs dominate headlines.

@Trace_Cohenยทt@nyvp.com